Literature DB >> 18305386

Mineral metabolism and mortality in dialysis patients: a reassessment of the K/DOQI guideline.

Marlies Noordzij1, Johanna C Korevaar, Friedo W Dekker, Elisabeth W Boeschoten, Willem J Bos, Raymond T Krediet, Patrick M Bossuyt, Ronald B Geskus.   

Abstract

BACKGROUND: Several studies found associations between higher plasma calcium and phosphorus and mortality in dialysis patients. However, different predefined categories and reference values were applied and the precise shape of these relationships remains unclear.
METHODS: We evaluated 1,621 patients from NECOSAD, a prospective multicenter cohort study of incident dialysis patients (60 +/- 15 years, 61% male, 64% hemodialysis). We used multivariate Cox regression and restricted cubic spline regression to study the effects of time-updated plasma concentrations on mortality in a flexible manner.
RESULTS: 486 patients (30%) died during follow-up. Elevated phosphorus concentration was associated with higher mortality (p = 0.0009). The association of high calcium with mortality was borderline significant (p = 0.07). Within the studied ranges, we could not identify a threshold where an appreciable change in mortality risk occurred.
CONCLUSIONS: Mortality risk started to increase at a relatively low phosphorus concentration (4.5 mg/dl). Low-normal calcium combined with low-normal phosphorus concentration was associated with the lowest mortality. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305386     DOI: 10.1159/000118847

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  6 in total

1.  Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease.

Authors:  Mehmet Kanbay; Mardare Nicoleta; Yusuf Selcoki; Mustafa Ikizek; Murat Aydin; Beyhan Eryonucu; Murat Duranay; Ali Akcay; Ferah Armutcu; Adrian Covic
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-24       Impact factor: 8.237

2.  Prescribed dietary phosphate restriction and survival among hemodialysis patients.

Authors:  Katherine E Lynch; Rebecca Lynch; Gary C Curhan; Steven M Brunelli
Journal:  Clin J Am Soc Nephrol       Date:  2010-12-09       Impact factor: 8.237

3.  Hyponatremia, mineral metabolism, and mortality in incident maintenance hemodialysis patients: a cohort study.

Authors:  Sagar U Nigwekar; Julia Wenger; Ravi Thadhani; Ishir Bhan
Journal:  Am J Kidney Dis       Date:  2013-04-13       Impact factor: 8.860

Review 4.  Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis.

Authors:  Jaime L Natoli; Rob Boer; Brian H Nathanson; Ross M Miller; Silvia Chiroli; William G Goodman; Vasily Belozeroff
Journal:  BMC Nephrol       Date:  2013-04-17       Impact factor: 2.388

5.  The impact of an "acute dialysis start" on the mortality attributed to the use of central venous catheters: a retrospective cohort study.

Authors:  Karthik K Tennankore; Steven D Soroka; Bryce A Kiberd
Journal:  BMC Nephrol       Date:  2012-07-30       Impact factor: 2.388

6.  Low serum phosphate as an independent predictor of increased infection-related mortality in dialysis patients: A prospective multicenter cohort study.

Authors:  Ji-Eun Lee; Jeong-Hoon Lim; Hye Min Jang; Yon Su Kim; Shin-Wook Kang; Chul Woo Yang; Nam-Ho Kim; Eugene Kwon; Hyun-Ji Kim; Jeung-Min Park; Hee-Yeon Jung; Ji-Young Choi; Sun-Hee Park; Chan-Duck Kim; Jang-Hee Cho; Yong-Lim Kim
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.